▶주메뉴 바로가기
▶본문 바로가기
Cross-border mergers and acquisitions are increasingly being tested not only on strategic fit or financial value, but also through the broader and often opaque filter of national security. Deals are being scrapped at the last minute as governments invoke security concerns, while in other cases acquirers are pressured to accept unfavorable conditions to win regulatory approval. South Korean dealmakers are no exception, facing setbacks in efforts to buy or sell businesses and losing critical time
Woori Bank said Sunday it has completed an $825 million refinancing for a 950-megawatt combined-cycle gas turbine power plant in Trumbull County, Ohio, as the facility enters commercial operation. The project is a joint investment with Korea Southern Power Co., the Korea Overseas Infrastructure & Urban Development Corporation and Siemens Energy. Following the plant’s April 15 start-up, Woori led the refinancing of construction loans into long-term facility financing. The plant sits within the PJ
Hanwha Group is set to launch a new holding company in August after securing preliminary listing approval from the Korea Exchange, as part of a broader governance overhaul. The exchange said Thursday that the proposed entity, tentatively named Hanwha Machinery & Services Holdings, meets Kospi listing requirements. The company is scheduled to be established on Aug. 1 and listed on Aug. 25. The new entity will be spun off from Hanwha Corp. and will oversee a portfolio of tech and lifestyle affilia
Hanwha Aerospace’s attempt to acquire Poongsan Corporation's ammunition unit has fallen through, likely due to a pricing gap, according to industry sources. Hanwha Aerospace said Thursday it had “reviewed various business opportunities, including Poongsan’s ammunition division, but decided to halt its acquisition review,” after Poongsan announced it was no longer pursuing a sale. The move follows reports last week that Hanwha had submitted a final bid for the unit. Market estimates had valued a
Real estate asset manager Vestas Investment Management said Tuesday it has formed a strategic partnership with Singaporean real estate investment firm City Developments Limited to target domestic hospitality investments. Founded in 1963, CDL is a real estate investment firm listed on the Singaporean stock market with a capitalization of approximately 7.5 trillion won ($5 billion). It specializes in residential and commercial real estate, as well as the hotel industry. Under the partnership, CDL
LS Electric said Monday that its subsidiary LS Power Solution has secured a $70.26 million contract with a US energy infrastructure company to supply extra-high-voltage transformers. Under the deal, LS Power Solution will deliver 345-kilovolt transformers for a microgrid powering a large-scale data center in the central US, with shipments scheduled from the fourth quarter of 2027 through the first half of 2028. The contract comes as demand for electricity surges alongside the rapid expansion of
Hahn & Co. said Wednesday it has agreed to sell used-car platform K Car and its financing unit to a consortium led by KG Group for 750 billion won ($498 million). Under the deal, Hahn & Co. will transfer a 72.19 percent controlling stake in K Car and a 100 percent stake in K Car Capital. The transaction values K Car at 980 billion won and K Car Capital at 200 billion won. KG Group described the acquisition as a “strategic turning point” as it seeks to build an integrated mobility ecosystem spann
GM Korea said Wednesday it will invest $600 million in its South Korean operations to upgrade production facilities and strengthen the competitiveness of its small SUVs, effectively putting speculation about a potential pullback from the country to rest. The investment will be used to upgrade production equipment, including the installation of new press machines at its plant in Bupyeong-gu, Incheon; improving safety infrastructure and working conditions; and boosting operational efficiency at it
Samsung Bioepis and Epis NexLab, subsidiaries of Samsung Epis Holdings, have signed a joint research and licensing agreement with Korean biotech G2GBio to develop long-acting obesity treatments, the companies said Monday. The tripartite agreement aims to develop obesity drugs with extended dosing intervals and secure advanced drug delivery technologies using G2GBio’s microsphere-based platform. Under the deal, Samsung Bioepis will obtain development and commercialization rights to G2GBio’s pipel
Chipotle bets on Korea for first bite of Asia
Samsung vs. LG battle for AI cooling heats up
Musinsa posts record earnings on offline, global expansion
One purchase every 0.9 second: Olive Young foreign sales top W1tr
Samsung, SK hynix tax payments surge 167% on chip boom
SK Chemicals eyes European can-coating market
Sept. 2, 2026
May 7, 2026
May 3, 2026
April 24, 2026
April 10, 2026
April 7, 2026
April 6, 2026
April 1, 2026
March 25, 2026
March 16, 2026
